Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ninaber, W. Hamersma, A. Schouffoer, A. Schuerwegh, J. Stolk (Leiden, Netherlands). An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis. Eur Respir J 2013; 42: Suppl. 57, 1926

Member's Comments

No comment yet.

Related content which might interest you: Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA) Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Gastro-oesophageal dismotility measurements in scleroderma-associated interstitial lung disease: Correlation with respiratory and reflux symptoms Source: International Congress 2015 – Connective tissue disorders Year: 2015 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Clinical analysis of lung manifestation in Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Respiratory work and its components during exercise in interstitial lung disease, COPD and controls Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2015 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170 Year: 2007 OSA with intertitial lung diseases Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013